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Abstract
Background: To investigate the associations between HLA-DRB1 shared epitope (SE) alleles and rheumatoid arthritis in
subsets of rheumatoid arthritis defined by autoantibodies in three Asian populations from Malaysia.
Methods: 1,079 rheumatoid arthritis patients and 1,470 healthy controls were included in the study. Levels of antibodies to
citrullinated proteins (ACPA) and rheumatoid factors were assessed and the PCR-SSO method was used for HLA-DRB1
genotyping.
Results: The proportion of ACPA positivity among Malay, Chinese and Indian rheumatoid arthritis patients were 62.9%,
65.2% and 68.6%, respectively. An increased frequency of SE alleles was observed in ACPA-positive rheumatoid arthritis
among the three Asian ethnic groups. HLA-DRB1*10 was highly associated with rheumatoid arthritis susceptibility in these
Asian populations. HLA-DRB1*0405 was significantly associated with susceptibility to rheumatoid arthritis in Malays and
Chinese, but not in Indians. HLA-DRB1*01 did not show any independent effect as a risk factor for rheumatoid arthritis in
this study and HLA-DRB1*1202 was protective in Malays and Chinese. There was no association between SE alleles and
ACPA- negative rheumatoid arthritis in any of the three Asian ethnic groups.
Conclusion: The HLA-DRB1 SE alleles increase the risk of ACPA-positive rheumatoid arthritis in all three Asian populations
from Malaysia.
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Introduction
Our knowledge on disease pathology and risk assignment in
rheumatoid arthritis is mainly based on studies of Caucasian
populations [1]. Investigations on different ethnic groups are,
however, relatively rare and have not followed the rapidly
increasing understanding of the genetic heterogeneity of rheuma-
toid arthritis (RA). There is thus a need for extended studies of
genetic as well as environmental risk factors in different ethnic
populations in order to achieve a deeper understanding of which
different molecular pathways that are involved in the pathogenesis
of different subsets of RA in different human populations.
Epidemiologic studies have demonstrated that RA is relatively
common in almost all populations of the world, albeit a somewhat
higher prevalence has been reported in Europe and the United
States as compared to Asia [2]. Detailed studies on interactions
between genetic and environmental risk factors for RA so far
mainly been reported from Europe and the USA, and have
demonstrated that the major genetic risk factor for RA, i.e.
presence of certain HLA-DRB1 (MIM ID*142857) alleles exert
their effects only in the subset of RA that is defined by the presence
of ACPA [3,4].
Human leukocyte antigens (HLA) account for one third to one
half of the total genetic contribution to RA susceptibility [5,6].
DRB1*0401, *0404 and *0408 are associated with RA in
Caucasians, while the disease is mainly associated with
DRB1*0405 in East Asians [7,8,9,10,11,12,13,14]. In other ethnic
groups, it has been well established that alternative HLA-DRB1
alleles might be associated with RA, either instead of or in addition
to DRB1*04.
It was recently shown that HLA-DRB1 SE alleles are associated
with increased levels of anti-citrullinated protein antibodies
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however, whether this selective association between ACPA-
positive RA and certain HLA-DRB1 alleles is valid in all ethnic
groups, in particular in groups with distribution of HLA-DRB1
alleles different from those described in Caucasians. Few studies
examining the relationship between HLA-DRB1 alleles and
subsets of RA have been published from other Asian populations
with slightly different results [10,19,20]. For example the DRB1
SE alleles were associated with both ACPA-positive RA cases
(OR=5.18) and ACPA-negative RA cases (OR=2.31) in a
Korean study, while no association between the DRB1 SE alleles
and subsets of RA was observed in the Chinese patients from
China (OR=0.52) [10,20].
Malaysia is a multiethnic country representing the genetic
diversity across multiple large populations i.e. Malay, Chinese and
Indian. In the present study, we determined the frequencies of the
HLA-DRB1-shared epitope alleles and investigated their associ-
ation with anti-citrullinated protein autoantibody-positive and
–negative RA in the three Asian populations from Malaysia.
Results
Presence of ACPA in Malaysian RA populations
Stratification analysis by ethnic groups showed comparable
prevalence of ACPA positivity in RA cases and controls. The
overall prevalence of ACPA positivity was 66.0% in RA cases and
3.3% in the controls. The SE-positivity was noted to be
significantly associated with RA in all the three ethnic groups
(Malay OR=3.98, 95%CI 2.94–5.40, p=2.74610
220; Chinese
OR=4.52, 95%CI 2.53–8.06, p=7.69610
28 and Indian
OR=2.16, 95% CI 1.49–3.12, p=4.09610
25) (Table 1).
Distribution of HLA-DRB1 genotype and risk of
developing ACPA-positive and ACPA-negative RA
In order to investigate the influence of HLA-DRB1 alleles with
regard to the risk of developing ACPA-positive RA or ACPA-
negative RA, we performed analyses stratified on ACPA status
among the cases. The frequencies of HLA-DRB1 alleles were
different for several DRB1 alleles among ACPA-positive and
ACPA-negative RA patients in comparison with ethnically
matched controls as demonstrated in Table 2, Table 3 and
Table 4 for Malay, Chinese and Indian ethnic groups, respectively.
In Table 2 the frequencies of DRB1 alleles in the Malay controls
were similar to that previously reported [21]. A significant increase
in the frequency of DRB1*04 and DRB1*10 in cases with ACPA-
positive RA was seen in comparison with controls. Although
DRB1*16 tended to be positively associated with ACPA-positive
RA, and DRB1*07 was negatively associated with ACPA-negative
RA, these associations were not significant after correction for
multiple comparisons. The frequencies of DRB1 alleles in the
Chinese control subjects were comparable to that previously
reported in the Singapore Chinese population [13]. The presence
of DRB1*04 and DRB1*10 was significantly associated with an
increased risk of ACPA-positive RA, whereas the presence of
DRB1*03 and DRB1*14 alleles were significantly associated to a
decreased risk of ACPA-positive RA. However, the effect of
DRB1*03 was not statistically significant after correcting for
multiple comparisons. DRB1*09, another reported RA-associated
allele in Japanese and Korean populations, was common in both
the patient and control groups for the Chinese population
(Table 3). In Indians the DRB1*10 allele was significantly more
frequent among ACPA-positive RA cases than among control
subjects. Unlike the Malay and Chinese ACPA-positive RA,
DRB1*04 allele represented insignificant risk regarding ACPA-
positive RA among Indians. There was an increased frequency of
DRB1*01 in ACPA-positive RA compared to the control group
but this was not statistically significant. In addition, DRB1*13 may
have had a protective role in the ACPA-positive RA among the
Indian population (Table 4). We did not observe any DRB1 allelic
group significantly associated with an increased risk of developing
ACPA-negative RA in any of the three Asian ethnic groups.
Protective effects conferred by different HLA-DRB1 alleles
in relation to the presence or absence of shared epitope
alleles
To assess the influence of shared epitope alleles on the
association found for non-shared epitope alleles, we performed
analyses of data with individuals who had neither the shared
epitope nor the studied alleles as a reference group. In this study,
we observed that DRB1*1202 allele was independent of the shared
epitope in protection against disease development, both for ACPA-
positive and ACPA-negative RA in the Malay population
(p=0.002 and p=0.006, respectively). However, similar protec-
tive effect of DRB1*1202 allele was less significant for the Chinese
ACPA-positive RA (p=0.049) after the correction for shared
epitope alleles influence. Interestingly, we also found that
DRB1*1201 allele was significantly associated with susceptibility
to ACPA-positive disease in the Malays, independent of the shared
epitope alleles [OR 1.65 95% CI (1.13–2.42)] (Table 5).
Table 1. Baseline demographic characteristics of cases of rheumatoid arthritis (RA) and controls in MyEIRA, by ethnicity.
Characteristic Malay Chinese Indian
RA Controls RA Controls RA Controls
Female: Male n, (ratio) 386:64 (6:1) 809:105 (8:1) 187:36 (5:1) 172:25 (7:1) 290:41 (7:1) 232:39 (6:1)
Age, mean (SD) years 46.2 (11.8) 46.3 (11.3) 52.6 (11.2) 50.9 (11.5) 47.7 (10.9) 48.1 (10.6)
IgM RF positive (%) 204 (47.8) 31(4.0) 103(48.1) 6 (3.2) 172(55.1) 12 (4.9)
IgG RF positive (% ) 213 (49.8) 58 (7.4) 105 (49.1) 13 (7.1) 167 (53.5) 16 (6.5)
ACPA-positive (% ) 278 (62.9) 25(3.1) 144 (65.2) 7 (3.8) 223 (68.6) 9 (3.5)
SE* positive (% ) 146(36.0) 85(12.4) 70(34.3) 17(11.6) 143 (48.3) 65 (30.5)
RF: rheumatoid factor, ACPA: anti-citrullinated proteins antibody, SE: shared epitope.
*patients and controls carrying one or two alleles of shared epitope were classified as SE-positive.
The percentages calculated in each characteristic category were based on the number of available data.
doi:10.1371/journal.pone.0021069.t001
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group by ACPA status.
Malay
Cases
(n=405)(%)
Controls
(n=685)(%)
OR,
95% CI
1
Pv a l u e
(Pc)
DRB1*01
ACPA-positive 4 (2) - 0.97(0.31–3.08)
ACPA-negative 4 (3) 11(2) 1.69(0.53–5.38)
DRB1*03
ACPA-positive 16 (6) - 0.61(0.35–1.08)
ACPA-negative 15(10) 67(10) 1.03(0.57–1.86)
DRB1*04
ACPA-positive 98(38) - 4.10(2.93–5.73) 9610
218
(1610
216)
ACPA-negative 25 (17) 90(13) 1.33(0.82–2.16)
DRB1*07
ACPA-positive 31(12) - 0.54(0.36–0.82)
ACPA-negative 16(10) 139(20) 0.47(0.27–0.82) 0.0065(NS)
DRB1*08
ACPA-positive 6(2) - 0.43(0.18–1.04)
ACPA-negative 12(8) 36(5) 1.58(0.80–3.11)
DRB1*09
ACPA-positive 17(7) - 1.09(0.61–1.95)
ACPA-negative 9(6) 42(6) 0.98(0.47–2.07)
DRB1*10
ACPA-positive 38(15) - 6.11(3.45–10.82) 5610
212
(6610
211)
ACPA-negative 8(5) 19(3) 1.99(0.85–4.63)
DRB1*11
ACPA-positive 5(2) - 0.27(0.11–0.69)
ACPA-negative 11(7) 47(7) 1.08(0.55–2.14)
DRB1*12
ACPA-positive 118(46) - 0.76(0.57–1.01)
ACPA-negative 67(45) 363(53) 0.72(0.51–1.03)
DRB1*13
ACPA-positive 8(3) - 0.44(0.20–0.94)
ACPA-negative 10(7) 47(7) 0.98(0.48–1.98)
DRB1*14
ACPA-positive 14(6) - 0.58(0.32–1.06)
ACPA-negative 12(8) 62(9) 0.88(0.46–1.68)
DRB1*15
ACPA-positive 108(42) - 0.83(0.62–1.10)
ACPA-negative 79(53) 321(47) 1.28(0.90–1.83)
DRB1*16
ACPA-positive 29(11) - 1.91(1.16–3.12) 0.0094(NS)
ACPA-negative 15(10) 43(6) 1.67(0.90–3.10)
*The frequency of DRB1 genotypes in ACPA subgroups was calculated as the
number of ACPA-positive or ACPA-negative RA cases for a specific DRB1 allele
divided by the total number of cases within that ACPA subgroup (Malay: 256
ACPA-positive RA cases and 149 ACPA-negative RA cases).
1Individuals without the allele being investigated were used as the reference
group for the calculation of odds ratio (OR) and 95% confidence interval (95% CI).
Corrected p (pc) values were obtained by multiplying the uncorrected p values by 13.
NS: not significant.
doi:10.1371/journal.pone.0021069.t002
Table 3. Carrier frequencies of HLA-DRB1in the Chinese
ethnic group by ACPA status.
Chinese
Cases
(n=204)(%)
Controls
(n=164)(%)
OR,
95% CI1 P value (Pc)
DRB1*01
ACPA-positive 2(2) - 1.25(0.17–8.97)
ACPA-negative 1(1) 2(1) 1.41(0.11–1.79)
DRB1*03
ACPA-positive 9(7) - 0.36(0.16–0.78) 0.008(NS)
ACPA-negative 8(11) 28(17) 0.61(0.26–1.41)
DRB1*04
ACPA-positive 64(48) - 5.23(3.03–9.03) 6610
210
(7610
29)
ACPA-negative 13(18) 25(15) 1.23(0.59–2.56)
DRB1*07
ACPA-positive 7(5) - 0.86(0.32–2.33)
ACPA-negative 0(0) 10(6.) 0.11(0.01–1.86)
DRB1*08
ACPA-positive 14(11) - 0.77(0.38–1.56)
ACPA-negative 14(19) 22(13) 1.56(0.75–3.25)
DRB1*09
ACPA-positive 41(31) - 1.31(0.79–2.18)
ACPA-negative 14(19) 42(26) 0.7(0.35–1.39)
DRB1*10
ACPA-positive 10(8) - 13.36(1.69–105.78) 0.0016(0.0208)
ACPA-negative 4(6) 1(0.01) 9.59(1.05–87.36)
DRB1*11
ACPA-positive 11(8) - 1.06(0.46–2.44)
ACPA-negative 8(11) 13(8) 1.45(0.57–3.67)
DRB1*12
ACPA-positive 27(20) - 0.66(0.38–1.14)
ACPA-negative 19(26) 46(28) 0.92(0.49–1.72)
DRB1*13
ACPA-positive 4(3) - 0.48(0.15–1.57)
ACPA-negative 2(3) 10(6) 0.43(0.09–2.00)
DRB1*14
ACPA-positive 9(7) - 0.3(0.14–0.66) 0.0016(0.0208)
ACPA-negative 18(25) 32(10) 1.38(0.71–2.66)
DRB1*15
ACPA-positive 37(28) - 1.00(0.60–1.66)
ACPA-negative 26(36) 46(28) 1.45(0.80–2.61)
DRB1*16
ACPA-positive 21(16) - 1.00(0.54–1.88)
ACPA-negative 10(14) 26(16) 0.86 (0.39–1.88)
*The frequency of DRB1 genotypes in ACPA subgroups was calculated as the
number of ACPA-positive or ACPA-negative RA cases for a specific DRB1 allele
divided by the total number of cases within that ACPA subgroup (Chinese: 132
ACPA-positive RA cases and 72 ACPA-negative RA cases).
1Individuals without the allele being investigated were used as the reference
group for the calculation of odds ratio (OR) and 95% confidence interval (95%
CI).
Corrected p (pc) values were obtained by multiplying the uncorrected p values
by 13.
NS: not significant.
doi:10.1371/journal.pone.0021069.t003
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In order to investigate which DRB1*04 subtypes that associated
with ACPA-positive RA in the three Asian populations, high
resolution HLA-DRB1*04 subtype analysis was carried out in
DRB1*04 positive patients and controls. Table 6 shows the
frequency distribution of HLA-DRB1*04 subtypes among the
DRB1*04 positive and ACPA-positive or ACPA-negative RA
patients and controls.
The frequencies of DRB1*0405 were largely increased in the
Malay and Chinese ACPA-positive RA cases as compared to their
control groups. The Indian ACPA-positive RA cases displayed a
much more limited increased frequency of DRB1*0405 in
comparison with the controls and this difference was not
statistically significant. DRB1*0403 was significantly associated
with protection against ACPA-positive RA in all the three ethnic
groups. The predominance of DRB1*0403 in Indian patients and
controls resulted in a concomitant decrease in all other DRB1*04
subtype alleles including DRB1*0405. Further analysis of the
DRB1*04 subtype SE alleles (DRB1*0401, DRB1*0404,
DRB1*0405, DRB1*0408 and DRB1*0410) in the context of
ACPA subgroups revealed a significant association between
DRB1*04 SE alleles and ACPA-positive RA in all the three
ethnic groups. No DRB1*04 subtype conferred any significantly
increased risk of developing ACPA-negative RA in the Malaysian
populations. However, a trend towards an association between
DRB1*0404, and ACPA-negative RA was seen in the Indian
population but the number of observations was quite small.
Effect of single or double HLA-DRB1-shared epitope (SE)
alleles
As is seen from Table 7, presence of two SE alleles (double SE
alleles) conferred a higher risk than presence of single SE allele in
all three populations. Also in this analysis, we failed to observe any
significant risk of developing ACPA-negative RA in relation to the
presence of SE alleles. Furthermore, the presence of SE alleles was
a risk factor for IgM and IgG RF-positive RA in all three
populations (for IgM-positive RF, Malays, OR 5.82 [4.06–8.34];
Chinese OR 5.72 [3.02–10.83]; Indians OR 2.83[1.86–4.32]; for
IgG-positive RF, Malays, OR 5.55 [3.89–7.92]; Chinese OR 5.32
[2.81–10.07] and Indians OR 2.69[1.77–4.10]) as well as IgM and
IgG RF-negative RA in the Malay and Chinese populations, but
not in the Indian population (for IgM-negative RF, Malays, OR
2.52 [1.73–3.68]; Chinese OR 3.69 [1.93–7.07]; Indians OR
1.53[1.00–1.67]; for IgG-negative RF, Malays, OR 2.58
[1.76–3.78]; Chinese OR 3.96 [2.07–7.59] and Indians OR
1.62[1.04–2.54]). Because the majority of RF-positive/negative
patients with RA were also ACPA-positive, associations of RF-
positive/negative RA may be a consequence of the underlying
ACPA status. The presence of two SE alleles (double SE alleles)
was also conferred a higher risk than the presence of single SE
allele for both IgM and IgG RF in all three populations (data not
shown).
Discussion
The major finding in this study is that different DRB1 shared
epitope (SE) alleles, that are common in Asian but not Caucasian
populations confer a significant risk of developing ACPA-positive
RA, but not ACPA-negative RA in all three Asian populations
from Malaysia.
Previous studies have demonstrated a significant association
between the presence of SE alleles and risk for ACPA-positive RA
mainly in Caucasian, but also in some non-Caucasian populations
[22,23,24,25]. One study from Korea has, however, observed that
Table 4. Carrier frequencies of HLA-DRB1in the Indian ethnic
group by ACPA status.
Indian
Cases
(n=296(%)
Controls
(n=213)(%)
OR,
95% CI1
P value
(Pc)
DRB1*01
ACPA-positive 12(6) - 2.20(0.81–5.98)
ACPA-negative 4(4) 6(3) 1.50(0.41–5.44)
DRB1*03
ACPA-positive 19(10) - 1.01(0.52–1.96)
ACPA-negative 15(19) 20(9) 1.79(0.87–3.66)
DRB1*04
ACPA-positive 69(35) - 1.55(1.01–2.37) NS (NS)
ACPA-negative 26(27) 54(25) 1.09(0.63–1.89)
DRB1*07
ACPA-positive 45(23) - 0.79(0.51–1.25)
ACPA-negative 20(21) 57(27) 0.72(0.40–1.28)
DRB1*08
ACPA-positive 12(6) - 0.98(0.44–2.21)
ACPA-negative 8(8) 13(6) 1.40(0.56–3.49)
DRB1*09
ACPA-positive 7(4) - 3.83(0.79–18.64)
ACPA-negative 2(2) 2(1) 2.24(0.31–16.18)
DRB1*10
ACPA-positive 75(38) - 2.60(1.66–4.06) 2610
25
(3610
24)
ACPA-negative 21(22) 40(19) 1.21(0.67–2.19)
DRB1*11
ACPA-positive 10(5) - 0.61(0.27–1.36)
ACPA-negative 5(5) 17(8) 0.63(0.23–1.77)
DRB1*12
ACPA-positive 7(4) - 0.42(0.17–1.03)
ACPA-negative 9(9) 17(8) 1.19(0.51–2.78)
DRB1*13
ACPA-positive 16(8) - 0.33(0.18–0.61) 3610
23
(3610
22)
ACPA-negative 18(19) 44(21) 0.89(0.48–1.63)
DRB1*14
ACPA-positive 34(17) - 0.81(0.49–1.33)
ACPA-negative 19(20) 43(20) 0.98(0.53–1.78)
DRB1*15
ACPA-positive 87(44) - 1.28(0.86–1.90)
ACPA-negative 43(45) 80(38) 1.35(0.83–2.20)
DRB1*16
ACPA-positive 3(2) - 1.61(0.27–9.72)
ACPA-negative 0(0) 2(1) 0.55(0.02–12.30)
*The frequency of DRB1 genotypes in ACPA subgroups was calculated as the
number of ACPA-positive or ACPA-negative RA cases for a specific DRB1 allele
divided by the total number of cases within that ACPA subgroup (Indian: 200
ACPA-positive RA cases and 96 ACPA-negative RA cases).
1Individuals without the allele being investigated were used as the reference
group for the calculation of odds ratio (OR) and 95% confidence interval (95% CI).
Corrected p (pc) values were obtained by multiplying the uncorrected p values by 13.
NS: not significant.
doi:10.1371/journal.pone.0021069.t004
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susceptibility, independent of SE status, suggesting that the
association between HLA-DRB1 SE and ACPA-positive RA
might be dependent on ethnicity-dependent genetic variations. On
the other hand, the association between SE alleles (DRB1*0401,
*0404, *0405, *0410) and ACPA status was not found in the
Chinese Han RA patients by Xue et al [10,20]. However, the
discrepancy observed between Xue et al and our study for the
Chinese population could be explained by the relatively small
samples size (RA patients, n=81) and by the fact that not all SE
alleles (e.g not DRB1*01 and DRB1*10) were considered in the
analysis [10,20]. The results of our present study however
demonstrate that SE-positivity is highly associated with ACPA-
positive RA for all three ethnic groups in Asia, thus providing
support for the notion that this association is present also in some
non-Caucasian populations.
The percentage of RA patients possesing the SE alleles in
current study was comparable to those of other Asian populations
[10,11]. but was lower in comparison with Caucasians RA patients
(81.6% in Northern Irish and 87.7% in Southern Swedish)
[26,27]. On the other hand, the frequency of SE alleles in the
European healthy controls was also relatively high (54.9% in
Northern Irish and 50% in Southern Swedish), when compared
with various healthy controls in the Asian populations
[9,10,11,13,26,27]. Notably, out of the three ethnic groups in
our study, Indian RA patients and controls had a slightly higher
frequency of SE (56% in Indians RA vs. 28.6% in Indian controls),
though it was still lower than in European Caucasian populations
[26,27]. Despite the lower frequency of SE alleles in RA patients
and control subjects in our study, the estimated relative risk for SE-
positive individuals to develop ACPA-positive RA was comparable
to that noted for European Caucasians (OR 7.65 in Southern
Swedish [27] and OR 3.91 in Northern Irish [26]). This suggests
that similar genetic mechanisms may operate in several different
ethnic groups in HLA-DRB1-dependent immune activation for
RA pathogenesis.
HLA-DRB1*0401 and *0404 alleles are the most common SE-
encoding DRB1*04 subtypes associated with the ACPA-positive
RA in Caucasians [25,27]. These alleles were however, rare in our
population, while DRB1*10 was the most prevalent SE-encoding
allele in all three ethnic groups. Interestingly, the DRB1*10
specificity is associated with RA also among the Eastern European
[23] and Southern European populations [28], but it is seldom
found in Caucasians of the North European ancestries [25,27].
Another feature of the genetic background in our study revealed
a relatively low frequency of DRB1*01, another SE-encoding
DRB1 allelic group in the Malaysian RA populations. This is
parallelled by the HLA-DRB1 allele distribution seen in the
control subjects (approx. 2% in this study). Nevertheless, when the
DRB1*01 allele was observed more frequent in RA patients, it
demonstrated a more clear trend towards association, e.g in Indian
ACPA-positive RA patients. DRB1*01 is present at comparable
frequencies in various Caucasian populations including 20% in
Swedish, 23.3% in Spanish, and 25.3% in Northern Irish
[26,27,28]. We could not assess the risk effect between
DRB1*01 and RA development for the three Asian ethnicities
due to relatively small number of observations in our study
population.
Further analysis demonstrated a negative association between
DRB1*1202 allele and ACPA-positive RA in the Malay and
Chinese populations, suggesting a protective role of this allele.
After the correction for shared epitope alleles, DRB1*1202 which
encodes the motif
70DRRAA
74 was still significantly associated
with protection regarding ACPA-positive RA in these ethnic
groups. DRB1*1202 has been described by a few studies
[11,13,16,19,22,29]. However, only one study showed a protective
effect of DRB1*1202 in RA, but this effects was non-significant
and the study did not analyse ACPA-positive and –negative RA
subsets separately [11]. The DRB1*13 allele has been found
significantly decreased in RA patients compared to controls in
other studies [2,19,25,30,31]. In the present study, theDRB1*13
allele was significantly decreased among the ACPA-positive RA
cases compared with the controls in the Indian population,
suggesting a protective role of this allele regarding ACPA-positive
RA, though the sample set examined was relatively small and the
result need further confirmation.
In conclusion, our study describes the association between
ACPA-positive RA and certain HLA-DRB1 SE alleles that are
common in Asian but not in Caucasian populations, and it also
describes protective effects of some HLA-DRB1 alleles in an
Table 5. Association of DRB1*12 subtype alleles with the development of ACPA-positive or ACPA-negative RA among Malay and
Chinese carriers with or without the shared epitope.
Malay Chinese
Cases
(n=405)
Controls
(n=685) OR (95% CI) P value
Cases
(n=210)
Controls
(n=164) OR (95% CI) P value
ACPA-positive
No SE. no DRB1*12 65 291 Reference group 62 105 Reference group
No SE. DRB1*1201 72 195 1.65 (1.13–2.42) 0.01 10 28 0.60 (0.27–1.33) NS
No SE. DRB1*1202 7 113 0.28 (0.12–0.62) 0.002 2 14 0.24(0.05–1.10) 0.0489
SE. no DRB1*12 86 64 6.02 (3.95–9.16) 1.7610
218 47 13 6.12(3.07–12.20) 4.3610
28
SE. any DRB1*12 32 21 6.82 (3.70–12.59) 1.7610
211 16 4 6.77(2.17–21.18) 0.0002
ACPA-negative
No SE. no DRB1*12 72 291 Reference group 44 105 Reference group
No SE. DRB1*1201 45 195 1.03 (0.68–1.57) NS 17 28 1.44(0.72–2.91) NS
No SE. DRB1*1202 9 113 0.36 (0.17–0.74) 0.006 1 14 0.17(0.02–1.33) NS
SE. no DRB1*12 19 64 1.33 (0.75–2.37) NS 10 13 1.83(0.75–4.49) NS
SE. any DRB1*12 12 21 2.56 (1.19–5.46) 0.02 0 4 - -
doi:10.1371/journal.pone.0021069.t005
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for analysis of the relationship between specific HLA-DRB1
subtypes and specific immune reactions of potential importance
for the pathogenesis of RA. The possibility to analyze these
relationships further in different ethnic groups will be of major
importance for our understanding of which immune reactions that
may contribute to RA in different subsets in different parts of the
world, and to learn which genes and which mechanisms that
promote or counteract the pathogenic processes.
Materials and Methods
Study design
This is a multicenter case-control study entitled the Malaysian
Epidemiological Investigation of Rheumatoid Arthritis (MyEIRA)
similar to the Swedish EIRA study [32,33]. It involves incident
cases of rheumatoid arthritis (RA), derived from the population in
the Malay Peninsula. The recruitment period for the cases and
controls was carried out from July 2005 to December 2009.
Patients and control subjects
A total of 1,079 patients with RA and 1,470 healthy controls
were enrolled in the study. Of the 1,079 cases, 450 (41.7%) were
Malays, 223 (20.7%) were Chinese, 331 (30.7%) were Indians and
75 (7.0%) were of mixed ethnicities. Each case was defined as a
person who fulfilled the American College of Rheumatology
(ACR) 1987 revised criteria for the classification of RA [34]. All
potential cases were examined and diagnosed by rheumatologists.
Eight government hospital rheumatology units participated in this
study. Of the RA patients, 863 (86%) were females and 141 (14%)
Table 6. The frequency distribution of HLA-DRB1*04 subtypes among DRB1*04 positive and ACPA-positive or ACPA-negative RA
patients by ethnic group.
MalayJ Chinese¥ Indian1
Cases
(n,%)
Controls
(n,%)
OR,
95% CI P value
Cases
(n,%)
Controls
(n,%) OR, 95% CI P value
Cases
(n,%)
Controls
(n,%)
OR,
95% CI P value
DRB1*0401
ACPA-positive 3 (3.1) - 3 (3.1) - 21 (30.4) -
ACPA-negative 0 (0) 2 (2.2) 1 (7.7) 2 (8.0) 4 (15.4) 12 (22.2)
DRB1*0402
ACPA-positive 1 (1.0) - 0 (0) - 1 (1.0) -
ACPA-negative 0 (0) 2 (2.2) 0 (0) 0 (0) 0 (0) 0 (0)
DRB1*0403
ACPA-positive 8 (8.2) - 0.27, 0.11–0.65 0.0023 6 (9.5) - 0.27, 0.08–0.89 0.0253 26 (37.7) - 0.45, 0.22–0.93 0.0294
ACPA-negative 6 (24) 22 (24.4) 4 (3.1) 7 (28.0) 13 (50.0) 31 (57.4)
DRB1*0404
ACPA-positive 1 (1.0) - 6 (9.5) - 0 (0) -
ACPA-negative 2 (8.0) 7 (7.8) 1 (7.7) 1(4.0) 5 (19.2) 1(1.9) 12.6, 1.39–114.5 0.0208
DRB1*0405
ACPA-positive 81 (82.7) - 5.59, 2.91–10.76 7610
28 46 (73.0) - 03.83, 1.45–10.09 0.051 9 (13.0) -
ACPA-negative 10 (40.0) 46 (51.0) 4 (30.8) 10 (40.0) 2 (7.7) 4 (7.4)
DRB1*0406
ACPA-positive 2 (2.0) - 0.15, 0.03–0.72 0.0162 6 (9.5) - 0.15, 0.03–0.72 0.0162 0 (0) - 0.15, 0.03–0.72 0.0162
ACPA-negative 1 (4.0) 11 (12.2) 3 (23.1) 4 (16.0) 1 (3.8) 1 (1.9)
DRB1*0407
ACPA-positive 0 (0) - 0 (0) - 1 (1.4) -
ACPA-negative 0 (0) 0 (0) 0 (0) 1 (4.0) 0 (0) 0 (0)
DRB1*0408
ACPA-positive 0 (0) - 0 (0) - 5 (7.2) -
ACPA-negative 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 2 (3.7)
DRB1*0410
ACPA-positive 2 (2.0) - 0 (0) - 6 (8.7) -
ACPA-negative 0 (0) 0 (0) 0 (0) 0 (0) 1 (3.8) 3 (5.6)
DRB1*0401/*0404/*0405/*0408/*0410
ACPA-positive 87 (88.8) - 1.94, 2.36–10.73 1610
25 52 (81.3) - 13.72, 4.51–41.72 3610
27 41 (59.4) - 2.13, 1.03–4.4 0.0397
ACPA-negative 18 (72.0) 55 (61.1) 1.64, 0.62–4.32 0.3171 6 (46.2) 13 (52.0) 2.71, 0.65–11.29 0.1663 12 (46.2) 22 (40.7) 1.25, 0.49–3.20 0.6464
J,¥,1The frequency of DRB1 genotypes in ACPA subgroups was calculated as the number of ACPA-positive or ACPA-negative rheumatoid arthritis(RA) cases for a specific
DRB1 allele (DRB1*04 +)divided by the total number of cases within that ACPA subgroup (Malay :98 DRB1*04+/ACPA-positive cases, 25 DRB1*04+/ACPA-negative cases;
Chinese: 64 DRB1*04+/ACPA-positive cases, 13 DRB1*04+/ACPA-negative cases; Indian: 69 DRB1*04+/ACPA-positive cases, 26 DRB1*04+/ACPA-negative cases).
doi:10.1371/journal.pone.0021069.t006
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(Inter Quartile Range, IQR=2 years). Radiological findings were
recorded as absence or presence of hand joint erosions.
Radiographic erosion data was available for 974 RA patients
(90.3%). Out of these, 169 of 974 (17.4%) had erosive RA. Extra-
articular manifestations were noted in 11.7% of 974 RA patients:
sicca syndrome, n=52 (5.3%), pulmonary fibrosis, n=28 (2.9%),
rheumatoid nodules, n=19 (2.0%), secondary sjo ¨gren, n=14
(1.4%) and vasculitis, n=1 (0.1%). 50.3% and 50.8% of the RA
patients were positive for IgM and IgG RF, respectively. For each
case, a control subject was randomly selected taking into
consideration the subject’s age, sex and residential area. Controls
with a history of autoimmune disease were excluded. In this study,
the control subjects were recruited based on two methods: (i)
hospital-based healthy controls, which comprised mainly nurses
and allied health care workers from the same hospital as the
patients; and (ii) population-based healthy controls, residing in the
same geographic location as the patient. Of the 1,470 control
subjects, 448 or 30.5% were hospital-based controls, and 1,022
population-based controls. Of the control subjects, 1,213 (87.8%)
were females and 169 (12.2%) were males. All patients and
controls were unrelated and the ethnic background was assessed
by self-description based on questions on ancestry. For example,
an individual is defined as Malay ethnic group when both he/her
parents are Malays. Interracial marriages are fairly common
among the Malaysians. Therefore, individuals of interracial
marriage parents were categorized as others/mixed ethnicities
and they were excluded for the analysis. In our study, we restricted
only patients and controls with both parents from the same ethnic
group were included leaving 1,004 RA patients and 1,382 control
subjects for the analysis.
The baseline demographic characteristics of patients and
controls are shown in Table 1. Malays are an ethnic group of
Austronesian people predominantly inhabiting the Malay Penni-
sula. In Malaysia, the Malays forms the dominance race and make
up to 50% of the total population. The Chinese population
consists mainly of descendents of Han Chinese settlers from
Southern China, particularly the provinces of Fujian, Guandong
and Hainan. They represent the second largest ethnic group in
Malaysia, accounting 24% of the total population. The Indian
population is largely descendents from those who migrated from
Southern Indian during the British colonization of Malaya. The
Indian population is the third largest ethnic group (7% of the total
population) in Malay Pennisula. More than ninety percent of the
Indian migrants were ethnic Tamil, Telugus, Malayalees and the
remainder of the Indians comprising Punjabis, Bengalis, Gujaratis
and Sindhis from Northern India. All the participants were
informed about the research, and written consent was obtained.
The study was approved by the Medical Research and Ethics
Committee, Ministry of Health, Malaysia.
DNA extraction
White cells were separated from 20 ml of EDTA blood using
Ficoll Hypaque (Lymphoprep
TM, Axis-Shield PoC AS, Oslo,
Norway) and the DNA was extracted using the QIAamp DNA
Blood Mini kit from Qiagen (Hilden, Germany). All DNA was
stored at 220uC until tested.
HLA-DRB1 genotyping
Low to medium-resolution and high-resolution genotyping of
HLA-DRB1 alleles were performed by the polymerase chain
reaction and sequence-specific oligonucleotide probe hybridization
method using the LABTypeH SSO Class II DRB1 and LABTypeH
HD Class II DRB1 (One Lambda Inc., CA, USA), respectively,
with Luminex Multi-Analyte Profiling System (xMAP, Luminex
Corporation, Texas, USA), according to the manufacturer’s
instruction. The assignment of HLA typing was accomplished
using the HLA Fusion software (version 1.3.0) provided by the
manufacturer (One Lambda Inc., CA, USA). Among the HLA
DRB1 alleles, DRB1*01, DRB1*0401, DRB1*0404, DRB1*0405,
DRB1*0408, DRB1*0410 and DRB1*10 were defined as SE
alleles [25]. Any genotype with combination of two of these alleles
was considered to be double SE genotypes.
Autoantibody Measurements
ACPA were identified and quantified with Immunoscan-RA
Mark2 ELISA test (anti-CCP test, Malmo ¨, Sweden). Samples with
results $25 AU/mL were defined as positive. IgM and IgG
rheumatoid factor (RF) was determined by ELISA kits (Immuno-
Table 7. Risk of developing ACPA-positive or ACPA-negative RA among carriers of SE (single, double or any) in the MyEIRA study
population by ethnicity.
No SE* Single SE Double SE Any SE
Cases Controls Cases Controls OR (95% CI) Cases Controls OR (95% CI) Cases Controls OR (95% CI)
Malay
ACPA-positive 140 600 100 79 5.29 (3.74–7.48) 16 4 17.14(5.64–52.07) 116 83 5.85(4.18–8.18)
ACPA-negative 119 30 1.87 (1.18–2.97) 0 1.78 (1.12–2.82) 30 1.82(1.15–2.89)
Chinese
ACPA-positive 72 147 54 17 6.49 (3.51–11.98) 6 0 0.00(-)** 60 17 7.20 (3.92–13.23)
ACPA-negative 62 9 1.26 (0.53–2.97) 1 0.00(-)# 10 4.74 (0.16–143.20)
Indian
ACPA-positive 88 148 98 56 2.75 (1.81–4.16) 14 5 4.71 (1.64–13.52 112 61 2.89 (1.93–4.34)
ACPA-negative 65 29 1.10 (0.65–1.87) 2 1.09 (0.65–1.82) 31 0.91 (0.17–4.82)
*Cases and controls without SE genes were used as reference groups.
**Fisher exact two-tailed p value, p=0.0015.
#Fisher exact two-tailed p value, p=0.3, NS.
doi:10.1371/journal.pone.0021069.t007
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results .15 IU/ml were defined as positive.
Statistical analysis
Allele frequencies were obtained by direct counting. When only
one allele was detected in genotyping assay, the individual was
considered homozygous and the allele was counted twice. The
frequencies and odds ratios (ORs) with 95% confidence intervals
(95% CIs) of the alleles and genotypes of DRB1 were compared
between patients and control subjects using the Chi-square or
Fisher’s exact test, where appropriate. Corrected p (Pc) was
obtained by multiplying the observed p values by the number of
allelic group examined: 13 for HLA-DRB1. A probability of 0.05
(2 tailed) was used as a significance threshold. Student t-test was
performed for the mean age of the patients and control subjects
group. Standard software (SPSS 17.0 for Windows, SPSS Chicago,
IL, USA) was used for statistical analyses.
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